THORN RUN PARTNERS for NOVARTIS CORPORATION
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 19, 2018 | $60,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Jan 18, 2019 | $50,000 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Issues related to the Orphan Drug Tax.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| CHARLES B. THOMAS | — |
Health Issues HCR
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Neonatal drug issues.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| CHARLES B. THOMAS | — |
Medical/Disease Research/Clinical Labs MED
Issues related to biologics.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| CHARLES B. THOMAS | — |
Medicare/Medicaid MMM
Implementation issues related to the Patient Protection and Affordable Care Act (P.L.111-148). Issues related to the Part D coverage gap and the Medicare reimbursement of biosimilars.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JESSIE HOWE BRAIRTON | — |
| ALEX DELPIZZO | — |
| GARY PALMQUIST | — |
| ANDREW ROSENBERG | — |
| CHARLES B. THOMAS | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.